Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472141 - 472160 out of 476480 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (L01EX) other protein kinase inhibitors | RETEVMO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
USA | (L01EX01) sunitinib (adm: O) | SUTENT 12.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
USA | (L01EX01) sunitinib (adm: O) | SUTENT 12.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
USA | (L01EX01) sunitinib (adm: O) | SUTENT 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
USA | (L01EX01) sunitinib (adm: O) | SUTENT 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
USA | (L01EX01) sunitinib (adm: O) | SUTENT 37.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
USA | (L01EX01) sunitinib (adm: O) | SUTENT 37.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
USA | (L01EX01) sunitinib (adm: O) | SUTENT 50MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
USA | (L01EX01) sunitinib (adm: O) | SUTENT 50MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
USA | (L01EX02) sorafenib (adm: O) | NEXAVAR 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BayerHealthCarePharmaceuticals,Inc. |
USA | (L01EX02) sorafenib (adm: O) | NEXAVAR 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BayerHealthCarePharmaceuticals,Inc. |
USA | (L01EX02) sorafenib (adm: O) | NEXAVAR 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BayerHealthCarePharmaceuticals,Inc. |
USA | (L01EX02) sorafenib (adm: O) | NEXAVAR 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BayerHealthCarePharmaceuticals,Inc. |
USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |